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Abstract
Traditional Chinese medicine (TCM) has been practiced for thousands of years, but only within the last few decades has its
use become more widespread outside of Asia. Concerns continue to be raised about the efficacy, legality, and safety of
many popular complementary alternative medicines, including TCMs. Ingredients of some TCMs are known to include
derivatives of endangered, trade-restricted species of plants and animals, and therefore contravene the Convention on
International Trade in Endangered Species (CITES) legislation. Chromatographic studies have detected the presence of
heavy metals and plant toxins within some TCMs, and there are numerous cases of adverse reactions. It is in the interests of
both biodiversity conservation and public safety that techniques are developed to screen medicinals like TCMs. Targeting
both the p-loop region of the plastid trnL gene and the mitochondrial 16S ribosomal RNA gene, over 49,000 amplicon
sequence reads were generated from 15 TCM samples presented in the form of powders, tablets, capsules, bile flakes, and
herbal teas. Here we show that second-generation, high-throughput sequencing (HTS) of DNA represents an effective
means to genetically audit organic ingredients within complex TCMs. Comparison of DNA sequence data to reference
databases revealed the presence of 68 different plant families and included genera, such as Ephedra and Asarum, that are
potentially toxic. Similarly, animal families were identified that include genera that are classified as vulnerable, endangered,
or critically endangered, including Asiatic black bear (Ursus thibetanus) and Saiga antelope (Saiga tatarica). Bovidae,
Cervidae, and Bufonidae DNA were also detected in many of the TCM samples and were rarely declared on the product
packaging. This study demonstrates that deep sequencing via HTS is an efficient and cost-effective way to audit highly
processed TCM products and will assist in monitoring their legality and safety especially when plant reference databases
become better established.
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Introduction
Traditional Chinese medicines (TCMs) have been an integral
part of Chinese culture and the primary medicinal treatment for a
large portion of the population for more than 3000 years [1,2].
Outside of Asia there has been, in recent decades, a growing use of
TCMs where they are being taken in conjunction with, or as an
alternative to, conventional Western medicine [3,4]. The increas-
ing popularity of TCM products has seen the monetary value of
the industry increase to hundreds of millions of dollars per annum
[5], its growth paralleled by the global increase in the use of
complementary and alternative medicines. Despite its increased
uptake, the therapeutic benefits of only a small number of TCM
products have been scientifically validated [6], with their perceived
efficacy being based largely on long-standing beliefs [7].
Chinese herbal medicines often contain numerous different
plant and animal-derived products that combine to act synergis-
tically to affect a desired outcome [8,9]. However, due to the
proprietary nature of TCM manufacture, coupled with a lack of
industry regulation, the biological origin of contents can be
difficult to determine with confidence, leading to questions
regarding TCM quality, efficacy and safety [10,11]. Undeclared
or misidentified TCM ingredients and adulterants can pose serious
health risks to consumers [10,12,13]. These include: allergenic
substances [14], plant toxins [7], heavy metals such as mercury,
lead, copper and arsenic [15], and pharmaceutically active
compounds of undetermined concentration [5]. In the early
1990s the misidentification of the toxic herb Aristolochia fangchi for
the anti-inflammatory agent Stephania tetrandra led more than a
hundred women to suffer kidney failure, with many later
developing cancer of the urinary system [13].
In addition to safety concerns, issues of legality also surround
TCMs. These concerns fall into three main categories: matters
relating to the trade of endangered species; issues pertaining to
honesty of food labelling; and adulteration of samples with drugs.
Some TCMs contain plant and animal species [16–18] that fall
under the jurisdiction of the Convention on International Trade in
Endangered Species (CITES). CITES-listed species (see appendi-
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use within TCM include: Asiatic black bear (Ursus thibetanus,
Appendix I listed), Saiga antelope (Saiga tatarica, Appendix II
listed), rhinoceros (all species, Appendix I listed), and non-
cultivated varieties of the plant genus Panax; P. ginseng and P.
quinquefolius, (Appendix II listed) [19–23]. The CITES appendices
include lists of species afforded different levels or types of
protection from over-exploitation. Appendix I species are deemed
the most endangered and threatened with extinction, with
Appendix II and III listed species regarded to be at lower, but
still significant, threat levels [24]. With an increased international
demand for TCMs, ascertaining the biological origins, and hence
the CITES status, of ingredients contained variously in capsules,
powders, liquids, and tablets represents a complex problem for
customs officials. The second issue of legality concerns the
mislabelling of TCMs. This might be done intentionally in order
to reduce manufacturing costs, or to circumvent customs’ scrutiny,
or inadvertently if the TCM practitioner unwittingly uses a
misidentified product [25]. For CITES member states to enforce
legislation and to prosecute cases of illegal trade, reliable methods
of species identification are needed [26]. Lastly, a number of TCM
products appear to have been intentionally adulterated with drugs
of known pharmacological activity such as anti-hyperglycaemic
agents (anti-diabetic medication) and corticosteroids [5], presum-
ably as a means to increase their efficacy.
To date, many of the analyses and identification of botanical
components in TCM products have employed chromatographic
methods [9,27]. However, these methods may not be able to
identify animal species, or be able to uncover all of the ingredients
within heterogeneous samples. DNA technology has the potentialto
provide information about species composition and the honesty of
ingredient declarations. For the identification of botanical constit-
uents used in TCMs, the genetic techniques employed include
fragment length polymorphism analysis, dot-blot hybridization,
micro-arrays, and sequencing of plastid DNA genes [25,28–33].
Likewise,geneticidentificationofanimalspeciescommonlyinvolves
DNA sequencing and characterisation of mitochondrial DNA
(mtDNA) genes [1,32,34]. Despite the variety of genetic work that
has been conducted to date, investigative research seems to have
focused on detecting the DNA of specific targets within TCMs
[22,28,30,35–38] or herbal teas [39] rather than investigating all of
the contributing species within a sample simultaneously.
The advent of Second Generation, high-throughput sequencing
(HTS) platforms have enabled the rapid sequencing of genes,
genomes and metagenomes [40]. The ability of these technologies
to deep-sequence both PCR amplified plastid and mtDNA
markers (using molecular identifier [MID] tags) has allowed the
species composition of a variety of complex substrates including
faecal material [41], sediments [42] and even, in a forensic
context, microbial communities on computer keyboards [43], to
be determined. The application of HTS technologies to analyse
complementary medicines has not been previously attempted, but
is likely to prove to be the best approach by which to genetically
audit the species composition of multiple TCM samples in parallel.
Given the worldwide popularity, growing use and increasing
financial significance of TCMs, an effective means of evaluating
these medicines is urgently needed – a sentiment echoed by
strategy reports from the World Health Organization (WHO)
[11]. This study sets out to explore the probative value of HTS
approaches by generating species audits from 15 TCMs (Figure 1;
Table 1) seized by border protection officials upon entry into
Australia.
Results/Discussion
General overview of HTS results
An in-depth genetic audit of the species constituents contained
within 15 TCM samples (Figure 1, Table 1) was determined by
using amplification of trnL (p-loop, plastid) and 16S rRNA
(mtDNA) genes, followed by deep sequencing via HTS (see
methods). More than 49,000 sequence reads were obtained from
the HTS approach using both trnL c/h and 16S primers, with the
analysis of the plant and animal constituents discussed separately
below. The DNA isolated from the various TCM samples was
highly variable in quality. Using trnL and 16S primers in qPCR
assays, DNA of sufficient quality was obtained from 15 of 28 (54%)
samples attempted. Some of the TCMs failed to amplify due to
severe PCR inhibition, while others yielded little, or no DNA. As
with many other degraded/processed substrates it may be
necessary to optimise DNA extraction methodologies depending
on the physical and chemical properties of the TCM.
To our knowledge, this is the first study to apply an HTS
approach to ascertain the species composition of medicinal
products. Until recently, to dissect the molecular components of
heterogeneous biological samples (such as TCMs) it has been
necessary to clone amplicons into plasmid vectors and then
sequence the insert. In direct contrast to previous cloning based
methodologies HTS provides deeper coverage of more samples in
a shorter time period, and represents a cost effective way to audit
DNA in heterogeneous samples. The sequencing of indexed
(MID-tagged) PCR amplicons [44] allows for the sequencing of
multiple samples in parallel, with the GS Junior or Ion Torrent
conservatively generating ,50,000 reads for c. US$1000 [45].
DNA isolation and quantification of 15 TCM samples followed by
a single HTS run of the pooled and tagged PCR products, was
estimated, in this case, to cost less than $35 per sample (excluding
labour). This demonstrates that after an initial outlay for MID-
tagged primers this approach is extremely cost-effective. As such,
the approach described here is both cost-effective, accessible, and
can be easily adapted to profile the molecular constituents of other
biologically derived complementary and alternative medicines.
One of the aims of this study was to determine the efficacy of HTS
auditing approaches specifically with the goal of screening
additional samples whose constituents might need to be identified
in cases involving illegal imports, food fraud, medicine fraud and
forensics.
Author Summary
Chemicals derived from plants and animals are widely used
in traditional Chinese medicine (TCM), and it is common-
place for remedies to contain a complex list of ingredients.
Due to their heterogeneous origins, and subsequent
processing into pills and powders, it can be difficult for
the biological origin of ingredients within each remedy to
be reliably determined. In this study, we have, for the first
time, used a second-generation DNA sequencing method
to analyse TCM remedies and determine their animal and
plant composition. Using this deep-sequencing approach
we identified plant species that are known to contain toxic
chemicals and identified animal DNA from species that are
currently endangered and protected by international laws.
Consumers need to be made aware of legal and health
safety issues that surround TCMs before adopting them as
a treatment option. More widespread testing of comple-
mentary medicines using the DNA methods developed
herein represents an efficient and cost-effective way to
audit their composition.
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species represents a complex problem, the accuracy of which
largely depends on the level of coverage afforded by reference
databases, the analytic method used [46] and the accuracy of the
underlying taxonomic framework. In the TCM data generated
here the vertebrate assignments were relatively straight forward, in
contrast to the plant assignments, which were particularly
challenging. The detection and identification to the family level,
of genetically well-characterised plants and animals is generally
uncomplicated. In contrast, if species-level assignments (without
uncertainties) are required for each trnL sequence, the task is
largely unachievable with current databases. While the MEta-
Genome ANalyzer (MEGAN) [47] based assignment approach is
not without problems, it is currently the best way to parse
thousands of sequence reads. Alternative methods for assigning
sequences are also available such as SAP [48] and QIIME [49]
although all of these methods are computationally intensive when
challenged with large volumes of data. Irrespective of the species
assignment methodology used, whether it be phenetic or
character-based, all are ultimately dependent on good reference
database coverage and a robust taxonomy.
There are a number of caveats with regards to HTS technology
that need to be considered when analysing data. Firstly the error
rate of 454 Titanium chemistry is estimated to be ,0.5–1% [50].
On top of this there is the possibility that recombination might
occur, albeit at a low (,0.3% on an Illumina platform) frequency
[51]. The likelihood of error and recombination should at least be
acknowledged, but with respect to the plastid trnL data presented
here it is debatable how significant an impact this is going to have
on species assignments due to the presence of both sequence and
length polymorphisms in the p-loop region. Lastly, caution also
needs to be exercised with drawing correlations between the
genetic profiles detected by HTS approaches and the actual
composition of the TCM. No genetic audit can detect DNA when
it has been completely degraded (for example by processing
procedures) and there will always be variation in the DNA
concentrations between ingredients. The results should therefore
be regarded as a qualitative, and potentially incomplete assessment
Figure 1. Photographs of four TCM samples genetically audited in this study using high-throughput sequencing. See Table 1 for a
detailed list of all samples and listed package ingredients. From left to right; (A) Bear Bile crystals (TCM-015), (B) Saiga Antelope Horn powder (TCM-
011), (C) Yatong Yili Wan capsules (TCM-016), and (D) Babao Ching Hsin San powder (TCM-026).
doi:10.1371/journal.pgen.1002657.g001
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Sample ID Sample Name Packet Ingredients (as they appear in English)
Packet Ingredients (Translated from
Chinese)
TCM-001 Mongnan Tianbao Pills Radix ginseng, cornu cervi pantolrichum,
Hippocampus, radix morindae officinalis, testis
et penis callorhini, rhizoma curculinginis, herba
cistanches, radix polygoni multiflori, semen
cusculae, herba epimedii
Same as English listing
TCM-002 Kai Yeung Pills Astragalus refiexistipulus, ligusticum acutilbum,
agkistroban acutus, cnidicum officinale, panax
ginseng, angelica anomala pall, atractylis lancas
var. oveta, selinum japonicum miq, yanthium
strumarium, phellodendron amurense, rehmannia
glutinosa liboach, zaocys dhumnades, golden coin
tortoise, moachus, agkistrodon, calculus bovis, squama
manitis, fructus liquidamberis
Same as English listing
TCM-003 Ling Yang Ge Gen Cold Remedy Fructus forsythiae, radix ledebouriellae, flos
lonicerae, pericarpium citri reticulatae, radix
platycodi, folium mori, herba menthae, folium
perillae, radix glycyrrhizae, radix puerariae, herba
schizonepetae, cornu antelopis, fructus arctii,
fructus momordicae
Same as English listing
TCM-004 Capsulae Bearbile No English translation for ingredients list Rhizoma Coptidis powder, Rheum officinale
(rhubarb), Chrysanthemum, Angelica sinensis,
menthyl of brain
TCM-006 Laryngitis Pills - A Borax, Coptis rhizome, Toad cake, Cow
bezoar, Pearl, Musk, Bear gall
Same as English listing
TCM-011 Saiga Antelope Horn Powder 100% pure Saiga Antelope horn powder Horns of wild animals: stage, antelope, rhinoceros
TCM-013 Lingxin Mingmu Shangging Wan No English translation for ingredients list Rhizoma Coptidis, Rheum officinale (rhubarb),
China Clay/Plaster of Paris/Gypsum,
Chrysanthemum, Herba Menthae (powder),
Orange Peel, Angelica sinensis, Cicada
TCM-015 Bear Bile Powder Bear bile powder Same as English listing
TCM-016 Yatong Yili Wan No English translation for ingredients list Cicada oil/essence, pearl grains, liquorice,
Synthetic Rheum officinale (rhubarb), pigs’ bile,
borax, cicada in wine
TCM-018 Qingxuan Pian No English translation for ingredients list Herba Menthae, China Clay/Plaster of Paris/
Gypsum
TCM-020 Zhen Zhu plus Hou
Zao San Powder
Radix siemona sessilifolia, fructus preilla frutescens,
fructus amomi rotundus, radix aster tataricus,
ramulus uncana cum uncis, cordyceps sinensis,
pericarpium citri reticulata, bulbus fritillaria cirrosa,
radix platycodon grandiflorum, calculus macaca
Only in English
TCM-021 Laryngitis Pills - B Borax, Coptis rhizome, Toad cake,
Cow bezoar, Pearl, Musk, Bear gall
Same as English listing
TCM-024 Powder in 2 vials kept in red
box with bear outline
No English translation for ingredients list Bear gall, goose bile, gall wine, gall powder
TCM-026 Babao Ching Hsin San powder Pearl, bezoar, succinum, monkey bezoar, borneol,
chamoishorn, cinnabaris, chuan pei, poria,
scorpion, peppermint, rhynchophylla, radix
bupleuri, herba ephedra, rhizoma atractylodis
macrocephalae, rhizoma gastrodia, herba
agastachis, rhizoma coptidis, radix platycodi, hairy
kind of sage, radix sileris, jianghuo, agalloch,
pinellia tuberifera, putchuck, jiangchai, radix
scutellariae, periostracum cicadae, arisaema
with bile, minerals, others
Same as English listing
TCM-027 Chu pak hou tsao san powder Monkey bezoar, pearl, amber, bezoar, borneol,
bulbus fritillariae cirrhosae, asarum sieboldi,
carrdamomun, rhynchophylla, acorius granineus,
gleditschia japonica, radix glycyrrhizae, citrus
nobilis lour
Same as English listing
The descriptions listed in the table are taken verbatim, from the respective TCM. The taxonomy, scientific nomenclature, and format are also exactly as listed, including
any inaccuracies.
doi:10.1371/journal.pgen.1002657.t001
Deep Sequencing Animal and Plant DNA within TCM
PLoS Genetics | www.plosgenetics.org 4 April 2012 | Volume 8 | Issue 4 | e1002657Table 2. Selected plant families and genera identified in 13 TCM samples using HTS.
Sample ID
TCM-
001
TCM-
002
TCM-
003
TCM-
004
TCM-
006
TCM-
011
TCM-
013
TCM-
016
TCM-
018
TCM-
020
TCM-
021
TCM-
026
TCM-
027
Number of DNA sequences 7444 563 3964 4944 7619 4445 4421 2123 2112 850 7454 912 1831
Anacardiaceae 33
Apiaceae 3 3 3333
- Cymopterus nivalis 3*
Araceae 33
Araliaceae 33 3 3
Aristolochiaceae 33 3 3
- Asarum 3* 3* 3* 3*
Asteraceae 33 3333 33
Brassicaceae 33 3 3
- Isatis 3*
Caprifoliaceae 3
- Lonicera 3*
Cucurbitaceae 3 333
Cyratophyllaceae 3
- Ceratophyllum demersum 3* 3*
Elaeagnaceae 3
- Hippophae tibetana 3*
Ephedraceae 3
- Ephedra 3*
Fabaceae 33 33333333
- Glycyrrhiza uralensis 3* 3* 3* 3* 3* 3* 3* 3*
- Glycine max 3* 3* 3* 3*
- Sophora flavescens 3*
- Vigna 3*
Lamiaceae 33 3333 3333
- Mentha 3* 3* 3* 3* 3* 3*
Moraceae 3
- Morus alba 3*
Oleaceae 33
- Jasminum 3*
Paeoniaceae 3
- Paeonia 3*
Poaceae 33 3 3 33 3 3 3
- Sorgum bicolor 3*
- Hordeum 3*
Polygonaceae 33 3
Ranunculaceae 33 3 3 3
- Xanthorhiza simplicissima 3* 3*
- Epimedium myrianthum 3*
Rosaceae 33 33 3
- Agrimonia eupatoria 3*
- Prunus 3*
Rutaceae 33 3
- Zanthoxylum 3*
Scrophulariaceae 33
- Manuleae 3* 3*
Solanaceae 33 3 3
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ingredient.
Within the confines of a manuscript it is impossible to document
the significance of each of the ,50,000 reads in this audit, instead,
a summary of the data is presented (Table 2 and Table 3, and
Figure S1A–S1N) and the discussion will focus on some of the
more common, illegal or hazardous ingredients.
Analysis of plant DNA in the TCM samples
A total of 68 plant families were identified in this study with
48,682 DNA sequence reads (on average 3,745 per TCM sample)
generated using the trnL c/h primer set [52] for the 13 analysed
samples (Table 2). Six of the most common plant families that
were identified included Fabaceae, Asteraceae, Poaceae, Lamia-
ceae, Solanaceae, and Apiaceae, with 70% of the samples
containing at least three of these families (Table 2). Some of the
most common plant genera identified in the TCM samples were
Glycyrrhiza (liquorice root, Family Fabaceae), found in 62% of
samples, Mentha (mint, Family Lamiaceae), found in 46% of
samples and Asarum (wild ginger, Family Aristolochiaceae) found in
31% of samples. Mint is commonly included in medicines and is
used in TCM to treat gastrointestinal upset, gallbladder problems
and upper respiratory symptoms [53]. Likewise Glycyrrhiza uralensis,
or Chinese liquorice root, is a common component of TCM
remedies and is classified as one of the Chinese 50 fundamental
herbs [54]. Containing glycyrrhizin, G. uralensis can be processed
by microbes into 18b-glycyrrhetic acid — effective in the
treatment of peptic ulcers, as well as having antiviral and
antifungal activities [55]. Heavy harvesting of G. uralensis from
the wild for TCM products, has resulted in the threat of species
extirpation in Chinese provinces such as Gansu [56].
The results of the trnL audit on four samples, Yatong Yili Wan
(TCM-016), Laryngitis pills (TCM-006, TCM-021), and Lingxin
Mingmu Shangging Wan (TCM-013), indicated they contained
DNA with close (.98%) similarity to the genera Ephedra and/or
Asarum (Table 2). These TCMs could potentially pose a risk, as
compounds from these genera can be poisonous or toxic at high
dosages. Ephedra is classed as a poisonous herb, with Ephedra-
containing products having been banned by the U.S. Food and
Drug Administration (FDA) since 2004 [57]. Remedies that
contain Ephedra should only be prescribed by experienced
practitioners, as the therapeutic dose range is narrow [8].
Aristolochic acid, the same compound as contained in Aristolochia
species, a known nephrotoxin, hepatotoxin, and carcinogen
[27,58], may be contained in certain species of Asarum.F u r t h e r
compound specific testing (via metabolomics) of TCMs from
which Asarum DNA was detected (TCM-006; TCM-013; TCM-
016; TCM-021, Figure 2, Table 2) would be required to
determine whether this acid is actually present in the TCMs
analysed here.
One trade-restricted plant species commonly found in TCM
preparation is Panax ginseng (CITES Appendix II). Non-cultivated
P. ginseng is subject to CITES regulation only when in the form of a
whole root, or sliced parts of the root, and not after processing and
manufacture [23]. It was not possible using the conservative
assignment criteria implemented in MEGAN to definitively
identify the genus Panax, this is primarily because the bit-score
match was equally good with the genus Hedera (ivies). Both Panax
and Hedera are in the family Araliaceae and further molecular
characterisation is required to distinguish if one or both of these
genera are present in the TCM-001, TCM-011, TCM-018 and
TCM-027. Even if Panax is confirmed, the fact that all the TCMs
Table 2. Cont.
Sample ID
TCM-
001
TCM-
002
TCM-
003
TCM-
004
TCM-
006
TCM-
011
TCM-
013
TCM-
016
TCM-
018
TCM-
020
TCM-
021
TCM-
026
TCM-
027
Number of DNA sequences 7444 563 3964 4944 7619 4445 4421 2123 2112 850 7454 912 1831
Zingiberaceae 3 3
- Plagiostachys mucida 3*
*indicates top BLAST match $98%. A comprehensive audit is shown in Figure S1A–S1N.
doi:10.1371/journal.pgen.1002657.t002
Table 3. Animal genera identified in the TCM samples using HTS.
Sample ID
Number of DNA
sequences (excluding
Homo)
Ursus
thibetanus
(Bear) #
Saiga tatarica (Saiga
antelope) #
Bufo
(Asiatic
Toad)
Capra
(Goat)
Ovis
(Sheep)
Cervus
elephas
(Deer)
Bubalus
(Buffalo)
Bos taurus
(Cow)
TCM-001 48 3* 3*
TCM-003 59 3* 3*
TCM-006 124 3* 3
TCM-011 24 3* 3* 3*
TCM-015 29 3*
TCM-016 32 3*
TCM-021 52 3* 3*
TCM-024 98 3*
TCM-027 73 3*
*indicates top BLAST match $98%. The symbol # denotes that the species are CITES listed [24].
doi:10.1371/journal.pgen.1002657.t003
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them technically not subject to CITES legislation.
Additional plant taxa with purported medicinal activity
identified in the samples include Xanthorhiza simplicissima (Ranun-
culeae), and Sophora flavescens (Fabaceae). Xanthorhiza simplicissima
(Yellowroot) is a native American medicinal containing berberine
which is anti-inflammatory, astringent, hemostatic, antimicrobial,
anticonvulsant, immunostimulant, uterotonic and can temporarily
lower blood pressure [59]: the roots of Sophora flavescens contain
alkaloids such as oxymatrine and is commonly used to treat fever,
asthma, cancer and viral myocarditis [60,61]. Plant DNA
assigning to the families Cannabaceae, Ranunculaceae, and
Solanacea, which are known to contain medicinally important
species, were also recovered. However to resolve these sequences
Figure 2. MEGAN phylogram of plant components in Yatong Yili Wan capsules (TCM-016). The data was generated using trnL c/h fusion
primers and HTS using the Roche GS Junior. 2123 reads were queried against GenBank and parsed through MEGAN, SAP and QIIME (see Methods).
The assignments of both MEGAN and SAP (with posterior support) are shown. Size of red node labels is proportional to number of sequence reads at
each taxonomic level.
doi:10.1371/journal.pgen.1002657.g002
Deep Sequencing Animal and Plant DNA within TCM
PLoS Genetics | www.plosgenetics.org 7 April 2012 | Volume 8 | Issue 4 | e1002657beyond the family level another gene region would need to be
targeted, and this might reveal, for example, whether the
Solanaceae (Nightshade family) identified in four of the TCM
samples comprised S. chrysotrichum (Giant Devil’s Fig) which has
known pharmacological activity [62], or perhaps the less exotic
species such as potato or tomato.
The complexity and risk of possible drug interactions for
consumers using TCMs in combination with conventional
medicines could be heightened when there are poisonous or toxic
ingredients of unknown concentrations in herbal remedies that
may not be listed on the packaging (Table 1). Further to potential
adverse drug interactions is the possibility of ingesting allergenic
substances within herbal remedies, such as nuts, which can cause
anaphylaxis in those with severe allergy. DNA from the
Anacardiaceae (the cashew or sumac family) was detected in two
TCMs - nut proteins from this family are know allergens [63].
Likewise, Glycine (soybean) was detected in four TCMs and is
known to contain at least 16 potential protein allergens with the
potential to cause adverse reactions ranging from mild rashes to
life threatening systemic anaphylaxis [64]. However, our results
were unable to determine whether the recovered DNA is derived
directly from the nut/bean, or originates from other plant tissue.
The variety of species that the HTS technique can reveal when
analysing TCMs, is demonstrated by the results obtained for the
Yatong Yili Wan pills (TCM-016). This sample was one of the
most botanically complex, containing 16 identifiable plant
families. 2,124 DNA sequence reads, were assigned to a GenBank
reference database sequence (Table 2; Figure 2), based on cut-offs
in MEGAN (see methods). SAP analysis was also conducted on
representative sequences from each of the terminal nodes. Results
generated by SAP were in close accordance with the MEGAN
assignments with high posterior support. The two cases where no
assignment was made was the result of insufficient database
coverage – the method is reliant upon sufficient sequence coverage
to construct a phylogeny. A third assignment method was also
implemented, QIIME, the results of which were also in broad
agreement with the MEGAN and SAP assignments (Figure 2).
What is clear from the plant assignments of the HTS data is that
better reference databases involving multiple genes (such as: trnL,
rbcL, ITS and matK) are required to improve the species
assignment. A medicinal materials DNA barcode database
(MMDBD) is currently being generated and compiled to include
thousands of DNA reference sequences for these and other genes
covering species of plants, animals, insects and fungi that are
commonly used in TCM (available at; http://www.cuhk.edu.hk/
icm/mmdbd.htm) [31]. The recent work of the China barcode of
life group [65] which has sequenced ,6000 species may soon
rectify inadequacies in the plant databases. Despite the constantly
improving databases, the taxonomic framework under which the
DNA assignments operate also needs to be scrutinised. What is
reassuring about HTS data is that while the resolution may not
currently be available, efforts to improve databases and the
underpinning taxonomies are continually improving and hence
the accuracy of assignments can only get better.
With the potentially enormous volumes of plant data produced
(over 7,662 reads in the case of TCM-006), it is tempting to look
for quantitative signals in results, but owing to various factors
including differential preservation of DNA in the raw ingredients,
different processing techniques, variation in PCR efficiency (due to
amplicon length variation and primer binding site polymor-
phisms), a universal primer approach should be viewed as semi-
quantitative at best. In the worst-case scenario a constituent may
be entirely undetected, especially if it occurs at a very low
abundance.
Analysis of vertebrate DNA in the TCM samples
With the exception of human-derived sequences (which were
excluded), vertebrate genetic signatures were detected in nine
samples tested using two universal 16S rRNA primer pairs [66,67].
A total of eight animal genera were identified from 539 DNA
sequences (Table 3). The taxonomic assignments of the vertebrate
sequences were simpler in comparison to the plant assignments,
due to substantially better GenBank coverage, but as with other
forensic studies caution still needs to be exercised when assigning a
species in casework [68,69]. This study identified four TCM
samples - Saiga Antelope Horn powder (TCM-011), Bear Bile
powder (TCM-015), powder in box with bear outline (TCM-024)
and Chu Pak Hou Tsao San powder (TCM-027) – that were
found to contain DNA from known CITES listed species. Two of
these CITES species are classified by the IUCN Red List as
vulnerable (Ursus thibetanus) and one as critically endangered (Saiga
tatarica) (Table 3). The threat posed to these and other animal
species’ survival caused by the demand for TCM products is high
[7,18]. This highlights a serious concern for the conservation of
these species and it is evident that illegal hunting still persists
despite a high level of legal protection [70]. One hundred and
seventy five countries are signatories to CITES, including China
(member party since 1981) [24], yet penalties for illegal trafficking
are relatively minor and penalties are rarely enforced [18]. DNA
testing of highly processed medicines may assist in the successful
prosecution of individuals who seek to profit from the illegal trade
in endangered taxa. Likewise, such genetic screens will help to
legitimise those medicines that contain components that are not
trade restricted, but may still be confiscated on grounds of
suspicion (e.g. TCM-003, 006 and 021).
Of the samples analysed using the 16S rRNA primers, 44%
contained two or more animal species within the same sample
(Table 3). Some of these species, such as water buffalo (Bubalus
bubalis), Asiatic toad (of the genus Bufo), and domestic cow (Bos
taurus), are known for their use in medicinal products [27,71],
whereas use of goat (Capra hircus) is less well represented in the
literature and may be used as a substitute for traditionally used
animal species. As with all animal-containing products the
consumer needs to be aware of the possibility of zoonotic
pathogens, such concerns have been raised previously in the
context of TCM [7].
Consumers of TCMs need to be wary of honesty of food
labelling [72], as in 78% of samples, animal DNA was identified
that had not been clearly labelled on the packaging (in either
English or Chinese). This adulteration of medicine occurred in the
Saiga Antelope Horn powder (TCM-011; Table 1) which claimed
to be 100% pure, yet was found to also contain significant
quantities of goat (Caprine) and sheep (Ovine) DNA (Table 3). In
some TCMs, undeclared ingredients are used to reduce the cost of
manufacture of the medicine by increasing the bulk of the powder,
but it is impossible to determine why Caprine and Ovine appeared
in this product. Water buffalo (Bubalus bubalis), domestic cow (Bos
taurus) and deer species were also not listed on the packaging of
samples in which they were genetically identified (Table 1 and 3).
The inadvertent consumption of undeclared animal products
found in 78% of the medicines, such as bovid, risk violating certain
religious and/or cultural strictures.
Concluding remarks
The results of this study demonstrate that high-throughput
DNA sequencing methods are an invaluable tool for analysing
constituents within complex TCMs. The techniques used enabled
the identification of a larger number of animal and plant taxa than
would have been possible through morphological and/or
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analysis of highly processed and degraded DNA from TCMs,
including powders, crystals, capsules, tablets, and herbal tea. It is
manifestly obvious that if there are trade-restricted biological
materials in TCMs, or if they contain DNA from species known to
synthesise toxic compounds, that better methods of detection are
urgently required. Even in the 15 TCMs tested here, the
occurrence of CITES-listed species, potentially toxic/allergenic
plants and non-declared constituents was all too common.
However, it should also be noted that the detection of DNA from
a pharmaceutically active species does not necessarily indicate the
presence of bioactive compounds: metabolomic analyses can be
used in addition for the detection of specific compounds. For
example, the bear-bile powder (TCM-015; Table 1 and Table 3)
containing Asiatic black bear DNA was analysed using Gas
Chromatography Mass Spectrometry and yielded a mass spectra
consistent with ursodeoxycholic acid (data not shown), an active
component of bile that has been reported to reduce pain and
inflammation [73].
In the future, TCM screening approaches that involve both
genetic (for species composition) and metabolomic (for compound
detection) approaches could represent the best way to audit
complementary medicines. With regard to TCMs and comple-
mentary medicines as a whole, controls need to be implemented to
ensure consumer safety and to minimise impacts on protected
biota. It is also important that consumers are made fully aware of
legal and health safety concerns that surround TCMs before
adopting them as a treatment option. A recent opinion piece [74]
stated ‘‘if TCM is to take its place in the modern medicine cabinet, then it
must develop ways to prove itself’’ – we endorse this view and note that
it applies equally to safety as it does to medical efficacy.
Materials and Methods
Sample collection, DNA extraction, and quantification
Twenty-eight TCM samples were obtained from the Wildlife
trade section of the Department of Sustainability, Environment,
Water, Population and Communities after being seized by
Australian Customs and Border Protection Service at airports
and seaports across Australia. The samples were seized because
they contravened Australia’s international wildlife trade laws as
outlined under Part 13A of the Environment Protection and
Biodiversity Conservation Act 1999 (EPBC Act). The samples
were stored in a quarantine-approved facility within the laboratory
after being catalogued. TCM sample types included: powders, bile
flakes, capsules, tablets, and herbal tea. Small amounts of each
sample (between 70–290 mg) were dispensed into 2.0 mL
Eppendorf tubes and digested overnight, on a shaking heat block
at 55uC, in 700 ml–1500 ml of tissue digest buffer consisting of;
1 mg per mL proteinase K (Amresco, OH, USA), 20 mM Tris
pH 8.0 (Sigma, MO, USA), 2.5 mM EDTA (Invitrogen, CA,
USA), 5 mM CaCl2 (Sigma), 20 mM DTT solution (Thermo
Fisher Scientific, MA, USA), 1% SDS (Invitrogen), and milliQ
water.
All samples were centrifuged after digestion for 3 minutes at
16,8136g. 200 mL of supernatant was mixed with 1 mL of Qiagen
(CA, USA) PB buffer and transferred to a Qiagen (PCR cleanup)
spin column and centrifuged for 1 minute at 16,8136g. Two wash
steps followed (Qiagen AWI then AWII buffer) prior to elution of
DNA from the spin column membrane with 50 mL of 10 mM Tris
pH 8.0. The DNA extracts were then quantified via real-time
quantitative polymerase chain reaction (qPCR; Applied Biosys-
tems [ABI], USA) using trnL g/h [52] and 16S ribosomal RNA
(rRNA) [66,67] primers (Integrated DNA Technologies [IDT],
USA) (Primer sequences displayed in Table S1). Samples were
assessed for quality and quantity of DNA using qPCR at three
DNA dilutions (undiluted, 1/10, 1/100) to determine if successful
isolation of DNA was achieved, and to investigate the presence of
PCR inhibition. The trnL g/h qPCR assay was conducted in
25 mL reactions using ABI Power SYBR master mix together with
0.8 mMo ftrnL g and trnL h primers and cycled at 95uC for
5 minutes followed by 40 cycles of 95uC for 30 s, 50uC for 30 s,
72uC for 30 s, with a 1uC melt curve stage and a 10 minute final
extension at 72uC. The 16S qPCR was conducted using the same
conditions, except for the primer concentration used, which was
0.4 mM and an annealing temperature of 57uC. An optimal DNA
concentration, free of inhibition was selected and used for further
analysis. Samples with low template amounts and/or severe
inhibition were not processed further.
Amplicon generation
Fusion primers with unique 6 bp MID tags were designed [74]
for both the 16S rRNA [65,66] (,150 bp product for 16Smam,
,250 bp product for 16S1/2 degenerate primers [Table S1]) and
the p-loop region of trnL [52] (c/h primers generating a size
variable product averaging ,250 bp product [Table S1]) (IDT,
Australia). The trnL c/h primer sets were used to generate a longer
PCR amplicon for future HTS, instead of the trnL g/h primer set
(,100 bp) which were only used for initial quantification. For the
most part, when we used qPCR on the c/h and g/h primers, there
were no significant drops in detected copy number. For this reason
we selected the longer c/h set as it affords greater taxonomic
resolution. Ten samples were PCR amplified using both the trnL
c/h and 16S fusion primers, three samples were PCR amplified
using trnL c/h fusion primers only, and two samples were PCR
amplified with 16S fusion primers only. Amplicons were generated
via PCR for each sample in triplicate (Corbett Research, NSW,
Australia) and pooled in an attempt to reduce the effect of PCR
stochasticity. The trnL c/h PCR was carried out in a 25 mL total
volume including 4 mL of template DNA, with the following
reagents: 2 mM MgCl2 (Fisher Biotec, Aus), 16Taq polymerase
buffer (Fisher Biotec, Australia), 0.4 mM dNTPs (Astral Scientific,
Australia), 0.1 mg BSA (Fisher Biotec, Australia), 0.4 mM of each
primer, and 0.25 mL of Taq DNA polymerase (Fisher Biotec,
Australia). The PCR conditions were as follows: initial denatur-
ation at 95uC for 5 minutes, followed by 50 cycles of 95uC for
30 s, 50uC for 30 s, 72uC for 30 s, and a final extension at 72uC
for 10 minutes (Corbett Research, NSW, Aus). The 16S PCR was
carried out in 25 mL total volume including 4 mL of template
DNA, and the same dNTP, primer and buffer concentrations, but
with 2.5 mM MgCl2, 0.4 mg BSA, and 0.25 mL of AmpliTaq
Gold DNA polymerase (ABI) instead. The PCR conditions
included: initial denaturation at 95uC for 5 minutes, followed by
40 cycles of 95uC for 30 s, 54uC3 0s ,7 2 uC for 30 s, and a final
extension at 72uC for 10 minutes (Corbett Research, NSW, Aus).
All PCR amplicons were double purified using the Agencourt
AMPure XP Bead PCR Purification protocol (Beckman Coulter
Genomics, MA, USA). The purified PCR amplicons were then
electrophoresed together on the same 2% agarose gel to confirm
the presence of the amplicons and to allow estimates of DNA
concentration to be made based on comparisons between band
intensity, prior to approximate equimolar amplicon pooling for
emulsion PCR.
GS Junior run set up for HTS
To achieve the desired bead:template ratio, pooled PCR
amplicons were quantified using a synthetic 200 bp oligonucleo-
tide standard (of known molarity) with the Roche A and B primers
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standard and the pooled library was required to approximate the
optimal bead:template ratio. The Roche GS Junior run set up
included an emulsion PCR step, bead recovery, and the
sequencing run. All of these procedures were carried out according
to the Roche GS Junior protocols (http://www.454.com).
Analysis of GS Junior HTS data
The sequencing output Fasta (.fna) and Quality (.qual)
formatted files were processed using the following applications.
Reads were quality trimmed using BARTAB [76] with a
minimum acceptable quality score of 20, averaged over a window
size of five bases, then separated into sample batches using a map
file containing sample and primer-MID tag information. A non-
redundant data set was also generated for each sample. The
batched sample read primer and MID tag sequences were masked
with the cross_match application [77], for minimum match length
of 12 and minimum score of 20, then trimmed using trimseq [78].
An alternative means of data sorting was also employed and
involved using the ‘‘separate by barcode’’ and primer trim feature
in Geneious (v5.5). Once deconvoluted (based on MID tags) each
batch of reads was searched using BLASTn version 2.2.23 [79]
with a gap penalties existence of five and extension of two. The
low complexity filter option was set to false, and the number of hits
was limited to 100 and an expected alignment value less than 1e-
10. The BLASTn search was against the National Centre for
Biotechnology Information (NCBI) GenBank nucleotide NR
database [80], containing all GenBank, EMBL, DDBJ and PDB
sequences, a total number of 13,504,325 database sequence
entries. This dataset contained no EST, STS, GSS, environmental
samples or phase 0, 1 or 2 HTGS sequences, database posted date
was Oct 6, 2010 5:44 PM. This pipeline was automated in an
Internet-based bioinformatics workflow environment, YABI
(https://ccg.murdoch.edu.au/yabi/). The resultant BLAST files
were imported into the program MEtaGenome ANalyzer
(MEGAN version 4.62.1) [47] for taxonomic analysis and
assignment of amplicon plant and animal sequence data, using
the following lowest common ancestor parameters: min score of
65, top percent of 5, and min support of 1. To compare the
MEGAN assignments with other algorithms we conducted a SAP
analysis [48] on a subset of data from TCM-016 where Bayesian
trees were constructed from an alignment of at least 30
homologous sequences. QIIME [49] analysis was also implement-
ed. However establishing a valid reference alignment file proved
difficult for the trnL of some of the TCM taxa.
Data described herein is available in a processed and annotated
form from Dryad Digital Repository: http://dx.doi.org/10.5061/
dryad.8ps58rp2. Alternatively in its raw form from the short read
archive – accession number SRA047476.
Supporting Information
Figure S1 (A–N) MEGAN phylograms of plants identified in 13
TCMs after HTS of trnL c/h gene. The data parsed through
MEGAN is illustrated at the lowest taxonomic level according to
the LCA parameters used (see Methods). A summary figure which
combines the BLAST results from all 13 TCMs also shown in (N).
Data used to generate the phylograms can be obtained in a
processed form from Dryad Digital Repository: http://dx.doi.org/
10.5061/dryad.8ps58rp2.
(PDF)
Table S1 Mitochondrial and plastid primer sequences used in
this study.
(PDF)
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